Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Sell
23,000
-200
-0.9% -$23.4K 0.01% 486
2026
Q1
$2.79M Buy
23,200
+4,700
+25% +$543K 0.02% 457
2025
Q4
$1.95M Buy
18,500
+1,800
+11% +$169K 0.01% 540
2025
Q3
$1.4M Sell
16,700
-5,000
-23% -$412K 0.01% 606
2025
Q2
$1.72M Buy
21,700
+2,000
+10% +$159K 0.01% 547
2025
Q1
$1.77M Buy
19,700
+6,700
+52% +$626K 0.01% 519
2024
Q4
$1.29M Buy
13,000
+5,300
+69% +$546K 0.01% 586
2024
Q3
$874K Buy
+7,700
New +$915K 0.01% 667
2024
Q2
Sell
-2,100
Closed -$277K 1148
2024
Q1
$277K Hold
2,100
﹤0.01% 959
2023
Q4
$229K Sell
2,100
-100
-5% -$10.4K ﹤0.01% 978
2023
Q3
$226K Buy
2,200
+100
+5% +$10.8K ﹤0.01% 956
2023
Q2
$242K Hold
2,100
﹤0.01% 955
2023
Q1
$223K Sell
2,100
-1,500
-42% -$162K ﹤0.01% 946
2022
Q4
$399K Sell
3,600
-15,500
-81% -$1.58M ﹤0.01% 762
2022
Q3
$1.65M Hold
19,100
0.01% 387
2022
Q2
$1.74M Sell
19,100
-1,200
-6% -$106K 0.01% 391
2022
Q1
$1.67M Buy
20,300
+200
+1% +$15.8K 0.01% 432
2021
Q4
$1.54M Buy
+20,100
New +$1.6M 0.01% 463

Other funds holding MRK

Davenport & Co's MRK Position: Q2 2026 in Review

Davenport & Co increased its Merck (MRK) stake by 0.81% in Q2 2026, buying an estimated $254K and bringing the position to 271,897 shares worth $34.9M. The position accounts for 0.17% of the portfolio, ranked #130.

Davenport & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $154M in Q1 2019. 1,180 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Davenport & Co held 271,897 shares of Merck worth $34.9M as of Q2 2026.
  • Davenport & Co bought 2,172 Merck shares in Q2 2026, an estimated $254K.
  • Merck made up 0.17% of Davenport & Co's portfolio in Q2 2026, its #130 holding.
  • Davenport & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
  • Davenport & Co's Merck position peaked at $154M in Q1 2019.
  • 1,180 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Davenport & Co's 13F filing for Q2 2026, filed 13 Jul 2026.